BSX
Income statement / Annual
Last year (2024), Boston Scientific Corporation's total revenue was $16.75 B,
an increase of 17.61% from the previous year.
In 2024, Boston Scientific Corporation's net income was $1.85 B.
See Boston Scientific Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$16.75 B |
$14.24 B |
$12.68 B |
$11.89 B |
$9.91 B |
$10.74 B |
$9.82 B |
$9.05 B |
$8.39 B |
$7.48 B |
| Cost of Revenue |
$5.26 B
|
$4.35 B
|
$4.00 B
|
$3.76 B
|
$3.51 B
|
$3.18 B
|
$2.88 B
|
$2.66 B
|
$2.50 B
|
$2.24 B
|
| Gross Profit |
$11.49 B
|
$9.90 B
|
$8.68 B
|
$8.13 B
|
$6.40 B
|
$7.55 B
|
$6.94 B
|
$6.39 B
|
$5.88 B
|
$5.23 B
|
| Gross Profit Ratio |
0.69
|
0.7
|
0.68
|
0.68
|
0.65
|
0.7
|
0.71
|
0.71
|
0.7
|
0.7
|
| Research and Development Expenses |
$1.62 B
|
$1.41 B
|
$1.32 B
|
$1.20 B
|
$1.14 B
|
$1.17 B
|
$1.11 B
|
$997.00 M
|
$920.00 M
|
$876.00 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.57 B
|
$3.29 B
|
$3.10 B
|
$2.87 B
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.98 B
|
$5.19 B
|
$4.52 B
|
$4.36 B
|
$3.79 B
|
$3.94 B
|
$3.57 B
|
$3.29 B
|
$3.10 B
|
$2.87 B
|
| Other Expenses |
$1.29 B
|
$948.00 M
|
$803.00 M
|
$741.00 M
|
$789.00 M
|
$699.00 M
|
$156.00 M
|
-$124.00 M
|
-$37.00 M
|
-$39.00 M
|
| Operating Expenses |
$8.89 B
|
$7.55 B
|
$6.65 B
|
$6.30 B
|
$5.72 B
|
$5.81 B
|
$5.28 B
|
$4.86 B
|
$4.56 B
|
$4.24 B
|
| Cost And Expenses |
$14.14 B
|
$11.90 B
|
$10.65 B
|
$10.06 B
|
$9.23 B
|
$9.00 B
|
$8.16 B
|
$7.52 B
|
$7.07 B
|
$6.49 B
|
| Interest Income |
$107.00 M
|
$22.00 M
|
$10.00 M
|
$4.00 M
|
$3.00 M
|
$30.00 M
|
$3.00 M
|
$5.00 M
|
$5.00 M
|
$5.00 M
|
| Interest Expense |
$305.00 M
|
$265.00 M
|
$470.00 M
|
$341.00 M
|
$361.00 M
|
$473.00 M
|
$241.00 M
|
$229.00 M
|
$233.00 M
|
$284.00 M
|
| Depreciation & Amortization |
$0.00
|
$1.20 B
|
$1.14 B
|
$1.09 B
|
$1.12 B
|
$1.01 B
|
$894.00 M
|
$844.00 M
|
$815.00 M
|
$495.00 M
|
| EBITDA |
$2.60 B |
$3.45 B |
$2.74 B |
$2.52 B |
$1.51 B |
$2.21 B |
$2.59 B |
$2.01 B |
$1.23 B |
$360.00 M |
| EBITDA Ratio |
0.16
|
0.24
|
0.22
|
0.23
|
0.18
|
0.19
|
0.25
|
0.22
|
0.22
|
0.19
|
| Operating Income Ratio |
0.16
|
0.16
|
0.13
|
0.17
|
0.11
|
0.14
|
0.15
|
0.14
|
0.05
|
-0.04
|
| Total Other Income/Expenses Net |
-$321.00 M
|
-$358.00 M
|
-$508.00 M
|
-$123.00 M
|
-$1.12 B
|
-$831.00 M
|
-$84.00 M
|
-$352.00 M
|
-$270.00 M
|
-$323.00 M
|
| Income Before Tax |
$2.28 B
|
$1.99 B
|
$1.14 B
|
$1.08 B
|
-$138.00 M
|
$687.00 M
|
$1.42 B
|
$933.00 M
|
$177.00 M
|
-$650.00 M
|
| Income Before Tax Ratio |
0.14
|
0.14
|
0.09
|
0.09
|
-0.01
|
0.06
|
0.14
|
0.1
|
0.02
|
-0.09
|
| Income Tax Expense |
$436.00 M
|
$393.00 M
|
$443.00 M
|
$36.00 M
|
$2.00 M
|
-$4.01 B
|
-$249.00 M
|
$828.00 M
|
-$170.00 M
|
-$411.00 M
|
| Net Income |
$1.85 B
|
$1.59 B
|
$698.00 M
|
$1.04 B
|
-$140.00 M
|
$4.70 B
|
$1.67 B
|
$104.00 M
|
$347.00 M
|
-$239.00 M
|
| Net Income Ratio |
0.11
|
0.11
|
0.06
|
0.09
|
-0.01
|
0.44
|
0.17
|
0.01
|
0.04
|
-0.03
|
| EPS |
1.26 |
1.08 |
0.45 |
0.69 |
-0.0988 |
3.38 |
1.21 |
0.0759 |
0.26 |
-0.18 |
| EPS Diluted |
1.25 |
1.07 |
0.45 |
0.69 |
-0.0988 |
3.33 |
1.19 |
0.0747 |
0.25 |
-0.18 |
| Weighted Average Shares Out |
$1.47 B
|
$1.45 B
|
$1.43 B
|
$1.42 B
|
$1.42 B
|
$1.39 B
|
$1.38 B
|
$1.37 B
|
$1.36 B
|
$1.33 B
|
| Weighted Average Shares Out Diluted |
$1.49 B
|
$1.46 B
|
$1.44 B
|
$1.43 B
|
$1.42 B
|
$1.41 B
|
$1.40 B
|
$1.39 B
|
$1.38 B
|
$1.34 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
